Guardant raises FY2026 revenue guidance to $1.36B-$1.37B while targeting Shield cost per test of $200 by end of 2028
Open the sourceReported by Seeking Alpha, seekingalpha.com, 6 November 2026
Not scored
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Muhabbit only has the headline for this one. The full report is at seekingalpha.com.